|
|||||
|
|
Synthesis,Biological Evaluation and Molecular Docking of Novel Phenylpyrimidine Derivatives as Potential Anticancer Agents |
|
| Authors: | JIN Bo TAO Ye YANG Hongliang |
| Affiliation: | 1. Department of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, P. R. China; 2. Heilongjiang Key Laboratory for Animal Disease Control and Pharmaceutical Development, Harbin 150030, P. R. China; 3. School of Pharmaceutical Sciences, Jilin University, Changchun 130021, P. R. China |
| Abstract: | Based on our previous researches, a novel phenylpyrimidine pharmacophore model was proposed and fifteen derivatives were synthesized and characterized by means of spectroscopy methods. The inhibitory effects of them were screened against HeLa cell line by virtue of MTT assay in vitro. The results indicate some of the phenylpyrimidine derivatives exhibit potent biological activities. Among them, compounds 6g and 6h exhibit the best activity at half maximal inhibitory concentrations of 1.5 and 2.8 μmol/L, respectively. These compounds also exhibit good activities against HepG2 cell line and MCF-7 cell line. FLT-3 kinase was screened as the most potent molecular target. Computational docking between compound 6g and FLT-3 was carried out to interpret the binding mode. The results show phenylpyrimidine derivatives have effective antitumor activities, which provides a base for further research of them as antitumor agents. |
| Keywords: | Phenylpyrimidine Anticancer activity Molecular docking |
| 点击此处可从《高等学校化学研究》浏览原始摘要信息 | |
| 点击此处可从《高等学校化学研究》下载全文 | |